MedPath

Kaffes Stent in the Management of Post-surgical Biliary Strictures

Phase 3
Conditions
Benign Biliary Stricture
Cholangitis
Bile Duct Injury
Bile Duct Stricture
Biliary Stricture
Interventions
Device: Multiple plastic stents
Device: Metallic stent
Registration Number
NCT03716232
Lead Sponsor
Cairo University
Brief Summary

Post-surgical biliary strictures are common especially after cholecystectomy. Standard treatment involves the performance of multiple procedures over a 1 year period at least using several plastic stents to achieve permanent dilatation of these strictures.

Metallic stents have the theoretical benefit of absence of need of multiple sessions.

These strictures however are frequently very close to the hilum and thus previously considered a contraindication for insertion of metallic stents for the fear of occlusion of the contralateral ducts. Metallic stent migration is also a frequent problem.

The use of a metallic stent that is short and completely intraductal, in theory, should reduce the risk of stent migration.

This is a randomized controlled trial comparing the efficacy and safety of a short metallic intraductal stent to the conventional treatment which is multiple plastic stents. In cases with a stricture reaching or close to the hilum a technique is used to avoid obstruction of the contralateral ducts which is insertion of a 7 French plastic stent alongside the metallic stent.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Confirmed benign postsurgical biliary stricture by presence of all 3 of the following:

Ultrasound imaging or Magnetic resonance cholangiopancreatography (MRCP) showing biliary dilatation, Raised bilirubin and or alkaline phosphatase, History of biliary tree surgery within the previous year

  • Naïve to endoscopic therapy
  • Age > 18 years
Read More
Exclusion Criteria
  • Coagulopathy
  • Inability of patient to adhere to regular follow-up
  • Living-donor liver transplant patients
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Multiple plastic stentsMultiple plastic stents* All procedures will be performed under propofol sedation. Strictures will be identified by cholangiography and then dilated by a dilating balloon (diameter 6-10mm). A 10 French plastic stent will be inserted bypassing the level of the stricture. * Stent replacement and the addition of further stents will be planned after 3 months from the initial procedure and every 3 months until stricture resolution occurs with a maximum of four procedures. Balloon dilatation with a 6-10 mm balloon will be used in each session before stent insertion.
Metallic stentMetallic stentAll procedures will be performed under propofol sedation. Strictures will be identified by cholangiography and then dilated by a dilating balloon (diameter 6-10mm). A 4-6cm fully covered expandable metallic stent (Kaffes stent, Taewoong medical, Seoul, Korea) will then be deployed at the level of the stricture. In cases close to the hepatic hilum where the deployment of the stent is expected to reach one duct and possibly block another duct, a 7 Fr stent will be inserted prior to deployment of the metallic stent in the contralateral duct.. - Stent will be extracted endoscopically after 6 months.
Primary Outcome Measures
NameTimeMethod
Clinical success6 months after removal of stents

Proportion of patients with Absence of clinical or laboratory evidence of recurrence of biliary obstruction

Secondary Outcome Measures
NameTimeMethod
Technical successAt time of procedure

Proportion of patients with Successful deployment of stents

Stricture resolution at end of treatmentAfter 6 months in the metallic stent group and after 12 or 15 months in the multiple plastic stents group

Radiological resolution of the stricture at the time of removal of the stents (after insertion of 3 or 4 stents) and after removal of the metallic stent.

Occurrence of complicationsup to 6 months after the last procedure

occurence of any procedure-related complication

Trial Locations

Locations (3)

National hepatology and tropical medicine research institute

🇪🇬

Cairo, Egypt

Theodor Bilharz Institute

🇪🇬

Cairo, Egypt

Kasr Alaini University Hospital

🇪🇬

Cairo, New Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath